CClinicalTrials.gg
CompletedNCT07588841Updated May 15, 2026

Evaluation of Low Energy Level Laser Biostimulation at Different Energy Densities in the Treatment of Temporomandibular Joint Irregularities: A Retrospective Study

An interventional study of Low Level Laser Therapy and Dietary Supplement in Myalgia of Mastication Muscle, sponsored by Karadeniz Technical University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 15 Years and older. Per ClinicalTrials.gov, last updated 2026-05-15.

Sponsored by Karadeniz Technical University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 3 years 8 months after the study started (first participant enrolled Sep 2022, registered May 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
15 Years and older
Sex
All
01

Study summary

This clinical study aimed to evaluate the effectiveness of low-level laser therapy in patients with temporomandibular disorders (TMD), specifically disc displacement with reduction and myalgia. The study compared laser therapy with a soft diet approach to determine whether laser treatment provides additional benefits in reducing pain and improving jaw function

02

Conditions studied

  • Myalgia of Mastication Muscle
03

In context

Lead sponsor

Karadeniz Technical University is the lead sponsor of 145 studies on the registry; 18 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
15 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

Diagnosis of disc displacement with reduction (DDwR) and myalgia according to DC/TMD criteria Presence of temporomandibular joint pain and functional limitation Patients aged 18 years and older No previous temporomandibular joint (TMJ) treatment Absence of systemic diseases Willingness to participate and provide informed consent

Exclusion criteria

Exclusion Criteria:

History of previous TMJ treatment (e.g., conservative or surgical treatment) Congenital or inflammatory joint disease Severe systemic diseases Edentulous patients Children and adolescents in the active growth period Acute trauma history involving the TMJ region Inability or unwillingness to complete follow-up visits

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
100 participants (actual)

Study arms

  • Active comparator
    Low Level Laser Therapy

    Participants in this group received low-level laser therapy applied to the temporomandibular joint region according to the predefined treatment protocol. Laser therapy was administered for 2 minutes per joint over 9 treatment sessions. Patients were also advised to follow a soft diet during the treatment period.

    Other: Low Level Laser Therapy

  • Other
    soft diet group

    Soft Diet Group: Participants in this group did not receive laser therapy and were instructed to follow a soft diet during the study period. This group served as the comparison group for evaluating treatment outcomes.

    Other: Dietary Supplement

Interventions

  • OtherLow Level Laser Therapy

    Participants received low-level laser therapy applied to the temporomandibular joint region in addition to soft diet recommendations. Treatment was performed in 9 sessions according to the predefined laser protocol. Participants followed a soft diet regimen without receiving laser therapy and served as the comparison group.

  • OtherDietary Supplement

    Participants in this group did not receive laser therapy and were instructed to follow a soft diet during the study period. This group served as the comparison group for evaluating treatment outcomes.

06

What researchers measure

Primary outcomes

  1. Change in temporomandibular pain intensity measured by the Visual Analog Scale (VAS) from baseline to the end of treatment and follow-up

    Change in temporomandibular pain intensity was assessed using the Visual Analog Scale (VAS) from baseline to the end of treatment and follow-up. The Visual Analog Scale ranges from 0 to 10, where 0 indicates no pain and 10 indicates the worst pain imaginable. Higher scores represent greater pain severity.

    Time frame: 6 month

07

Study locations

1 site
  • Karadeniz Technical University
    Trabzon, Trabzon 61000, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No — Individual participant data (IPD) will not be publicly shared due to privacy and confidentiality considerations related to patient data

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 15, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07588841
Lead sponsor
Karadeniz Technical University
Responsible party
Emil Mahammadli (Assistant Professor, Karadeniz Technical University) — Principal investigator
First posted
May 15, 2026
Start date
Sep 3, 2022
Primary completion
Dec 24, 2024
Completion
Dec 24, 2024
Last update
May 15, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion